Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.

Pharmaceutical

Stada Group

Peter Goldschmidt

Patrick Genestin

Christos Gallis

Stéphane Jacqmin

Boris Doebler

Simone Berger

Christoph Dengler

Bryan Kim

Miguel Pagan Fernandez

Stephan Eder

Volker Sydow

Frank Staud

Yann Brun

The Global Quality Management Team at Stada Group ensures the highest standards of quality across all pharmaceutical products and processes worldwide. This team is responsible for conducting global audits, managing supplier qualifications, ensuring compliance with Good Manufacturing Practices (GMP), overseeing risk management, and handling global quality agreements. Their work helps maintain the integrity and safety of Stada's generics and branded products, ensuring they meet regulatory standards and deliver consistent performance in the healthcare market.

Global Quality Management Team

Marketing

Global Operations

Directors Team

Global Quality Management Team

About

Team members

Other teams at Stada Group

Marketing

Global Operations

Directors Team